Mechanochemical platform and sensing methods using DNA origami nanostructures
A biosensing platform capable of high throughput mechanochemical biosensing comprising a DNA origami nanostructure having a plurality of slots into which recognition elements are strategically placed and apparatus that senses a change in the origami nanostructure in response to the introduction of a target where the apparatus includes a signal transduction unit and signal sensor which exploits mechanical signals in a recognition element which signal includes one or more mechanical tension or mechanochemical rearrangement event. The nanostructure is preferably a 2-dimensional or 3-dimensional arrangement of tiles linked by locking elements, such as aptamers that will open in response to an event such as exposure to a drug molecule, DNA, RNA or protein target.
1. A biosensing platform which is capable of real time, high throughput mechanochemical biosensing, comprising:
a DNA origami nanostructure, comprising multiple, flat DNA tiles having a plurality of slots between the tiles into which target recognition elements are strategically placed to lock adjacent tiles together, wherein the DNA origami nanostructure is 2-dimensional or 3-dimensional and tethered on terminal ends between two optically trapped beads through dsDNA handles, and
optical tweezers that sense mechanical signals generated when the target recognition element binds with a target to disassemble the lock and unlock the tiles.
2. The biosensing platform as set forth in claim 1 , wherein the DNA origami nanostructure comprises more than 2 and less than 8 tiles, and wherein two or more adjacent tiles are interlocked by the target recognition elements.
3. The biosensing platform as set forth in claim 2 , wherein the target recognition elements each comprise an aptamer sequence and a complementary DNA strand.
4. The biosensing platform as set forth in claim 3 , wherein the aptamer based target recognition element changes its conformation upon binding with a specific target thereby disassembling the lock and unlocking the tiles.
5. The biosensing platform as set forth in claim 4 , wherein the aptamer portion of the target recognition elements comprises Platelet Derived Growth Factor (PDGF) aptamers.
6. The biosensing platform as set forth in claim 5 , in which the PDGF aptamer recognizes a target PDGF protein and changes its conformation to unlock the tiles.
7. The biosensing platform as set forth in claim 1 , wherein the tiles are approximately flat rectangles, and wherein the tiles have a dimension from 20 to 50 nm by from 15 to 35 nm.
8. The biosensing platform as set forth in claim 7 , wherein the DNA origami nanostructure is a 2-dimensional structure having a first end and a second end and is tethered between optically trapped beads by a dsDNA handle at each of the first end and the second end of the DNA origami nanostructure, wherein the dsDNA handles are attached to the first sequential tile and the last sequential tile of the DNA origami nanostructure, and wherein a change in force or bead-to-bead distance due to unlocking of the tiles is monitored in real time by optical tweezers.
9. The biosensing platform as set forth in claim 1 , wherein the mechanical signals include a change in a tension or mechanochemical rearrangement of the DNA origami nanostructure due to unlocking of the tiles.
10. The biosensing platform as set forth in claim 1 , wherein the lock formed by the target recognition elements opens in response to exposure and binding to a target and the opening occurs at a force between 10-25 pN.
11. The biosensing platform as set forth in claim 10 , wherein there are multiple events comprising the opening of the interlocks and the opening events occur one-by-one rather than simultaneous.
12. The biosensing platform as set forth in claim 1 , wherein at least two different target recognition elements are used in the same DNA origami nanostructure.
13. The biosensing platform as set forth in claim 2 , wherein at least three tiles of the DNA origami nanostructure are interlocked by the target recognition elements.
14. The biosensing platform as set forth in claim 12 , wherein the target recognition elements include either a toe-hold DNA segment or a PDGF aptamer, or a combination of both.
15. The biosensing platform as set forth in claim 14 , wherein the toe-hold DNA segment recognizes a target DNA sequence and the PDGF aptamer recognizes a PDGF protein and each recognition produces a different mechanical signal upon opening of the lock.